Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | 19,923 | reported | 13 Mar 2026 | tx 81+3,132,140−969,757 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 12,500 | — | |
| 13 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 7,308 | 55.23 USD | |
| 12 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 12,500 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 75,000 | 8.40 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 21,791 | 58.81 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 31,694 | 59.88 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 21,515 | 60.49 USD | |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 25,000 | 3.10 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 12,479 | 59.50 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 10,072 | 60.47 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 2,449 | 61.26 USD | |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 105,000 | 4.75 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 43,348 | 59.26 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 61,652 | 60.08 USD | |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 65,000 | 9.44 USD | |
| 09 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 65,000 | 62.06 USD | |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 20,000 | — | |
| 10 Mar 2026 | SALE | Xenon Pharmaceuticals Inc. | 11,269 | 60.11 USD | |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 65,000 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 75,000 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 105,000 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 20,000 | 0.00 USD | deriv |
| 09 Mar 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 20,000 | 0.00 USD | deriv |
| 09 Mar 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 25,000 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 65,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 10 Aug 2017.